Cite
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study.
MLA
Jourdes, Aurélie, et al. “Characteristics and Incidence of Infections in Patients with Multiple Myeloma Treated by Bispecific Antibodies: A National Retrospective Study.” Clinical Microbiology & Infection, vol. 30, no. 6, June 2024, pp. 764–71. EBSCOhost, https://doi.org/10.1016/j.cmi.2024.02.023.
APA
Jourdes, A., Cellerin, E., Touzeau, C., Harel, S., Denis, B., Escure, G., Faure, E., Jamard, S., Danion, F., Sonntag, C., Ader, F., Karlin, L., Soueges, S., Cazelles, C., de La Porte des Vaux, C., Frenzel, L., Lanternier, F., Brousse, X., Cazaubiel, T., & Berger, P. (2024). Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study. Clinical Microbiology & Infection, 30(6), 764–771. https://doi.org/10.1016/j.cmi.2024.02.023
Chicago
Jourdes, Aurélie, Elise Cellerin, Cyrille Touzeau, Stéphanie Harel, Blandine Denis, Guillaume Escure, Emmanuel Faure, et al. 2024. “Characteristics and Incidence of Infections in Patients with Multiple Myeloma Treated by Bispecific Antibodies: A National Retrospective Study.” Clinical Microbiology & Infection 30 (6): 764–71. doi:10.1016/j.cmi.2024.02.023.